1
Galla Chandra Rao, Christopher Larson, Madeline Repollet, Herman Rutner, Leon W M M Terstappen, Shawn Mark O Hara, Steven Gross: Analysis of circulating tumor cells, fragments, and debris. Veridex, January 4, 2011: US07863012 (36 worldwide citation)

The methods and reagents described in this invention are used to analyze circulating tumor cells, clusters, fragments, and debris. Analysis is performed with a number of platforms, including flow cytometry and the CellSpotter® fluorescent microscopy imaging system. Analyzing damaged cells has shown ...


2
Galla Chandra Rao, Christopher Larson, Madeline Repollet, Herman Rutner, Leon W M M Terstappen, Shawn Mark O Hara, Steven Gross: Analysis of circulating tumor cells, fragments, and debris. Veridex, Ruby T Hope, December 11, 2012: US08329422 (14 worldwide citation)

The methods and reagents described in this invention are used to analyze circulating tumor cells, clusters, fragments, and debris. Analysis is performed with a number of platforms, including flow cytometry and the CELLSPOTTER® fluorescent microscopy imaging system. Analyzing damaged cells has shown ...


3
Shawn Mark O Hara, Daniel Zweitzig: DNA polymerase activity assays and methods enabling determination of viable microbes. ZEUS Scientific, Graham C Alig, Wilkinson Law L L C, July 18, 2017: US09708651

A method for performing a diagnostic assay for the detection of the presence or amount of a microorganism within a sample matrix containing active DNA polymerase, is disclosed. The method utilizes the measurement of DNA polymerase extension activity, wherein the assay comprises the steps of incubati ...


4
Leon WMM Terstappen, Galla Chandra Rao, Shawn Mark O Hara, Paul A Liberti, Steven Gross, Gerald Doyle: Methods and reagents for the rapid and efficient isolation of circulating cancer cells. Dann Dorfman Herrell & Skillman, November 21, 2002: US20020172987-A1

Methods and compositions are provided for detecting circulating tumor cells and assessing said cells for alterations in tumor-diathesis associated molecules.


5
Galla Chandra Rao, Christopher Larson, Madeline Repollet, Herman Rutner, Leon WMM Terstappen, Shawn Mark O Hara, Steven Gross: Analysis of circulating tumor cells, fragments, and debris. Immunicon Corporation, August 18, 2005: US20050181463-A1

The methods and reagents described in this invention are used to analyze circulating tumor cells, clusters, fragments, and debris. Analysis is performed with a number of platforms, including flow cytometry and the CellSpotter® fluorescent microscopy imaging system. Analyzing damaged cells has shown ...


6
Shawn Mark O Hara, Daniel Zweitzig, Brad Foulk: Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample. Immunicon Corporation, January 12, 2006: US20060008807-A1

A highly sensitive assay is disclosed which utilizes a method for gene specific primed amplification of mRNA libraries from rare cells and rare transcripts found in blood. The assay allows detection of rare mRNA (10 copies/cell) found in 1 to 10 cells isolated through immunomagnetic enrichment. The ...


7
Shawn Mark O Hara, Denis Smimov, Daniel R Zweitzig: AGR2 and TFF3 Regulation in the Diagnosis and Treatment of Cancer. Philip S Johnson, Johnson & Johnson, March 11, 2010: US20100062426-A1

A method for assessing tumor progression is described by assessing AGR2 and/or TFF3 expression in a biological sample after induction of a physiological stress, such as hypoxia or serum deprivation in an enriched sample. Assessing the role of these indicators and their expression levels in an enrich ...


8
Galla Chandra Rao, Christopher Larson, Madeline Repollet, Herman Rutner, Leon WMM Terstappen, Shawn Mark O Hara, Steven Gross: Analysis of Circulating Tumor Cells, Fragments, and Debris. Veridex, May 5, 2011: US20110104718-A1

The methods and reagents described in this invention are used to analyze circulating tumor cells, clusters, fragments, and debris. Analysis is performed with a number of platforms, including flow cytometry and the CellSpotter® fluorescent microscopy imaging system. Analyzing damaged cells has shown ...


9
Shawn Mark O Hara, Mark James Kopnitsky: Methods And Compositions Including Diagnostic Kits For The Detection of Staphylococcus Aureus. May 12, 2011: US20110111399-A1

Methods and compositions, including diagnostic kits, for the detection of Staphylococcus Aureus (SA) and clinically important antibiotic resistant forms thereof, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Staphylococcus aureus (VRSA), mupirocin-resistant Staphyl ...


10
Shawn Mark O Hara: Methods and Compositions Including Diagnostic Kits For The Detection In Samples Of Methicillin-Resistant Staphylococcus Aureus. March 29, 2012: US20120077684-A1

The present invention provides methods, compositions and diagnostic kits for the detection of Staphylococcus Aureus (SA) and antibiotic resistant forms and variants thereof, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Staphylococcus aureus (VRSA), mupirocin-resis ...